Abstract

PDZK1 is a four-PDZ domain-containing scaffold protein that, via its first PDZ domain (PDZ1), binds to the C terminus of the high density lipoprotein (HDL) receptor scavenger receptor, class B, type I (SR-BI). Abolishing PDZK1 expression in PDZK1 knock-out (KO) mice leads to a post-transcriptional, tissue-specific decrease in SR-BI protein level and an increase in total plasma cholesterol carried in abnormally large HDL particles. Here we show that, although hepatic overexpression of PDZK1 restored normal SR-BI protein abundance and function in PDZK1 KO mice, hepatic overexpression of only the PDZ1 domain was not sufficient to restore normal SR-BI function. In wild-type mice, overexpression of the PDZ1 domain overcame the activity of the endogenous hepatic PDZK1, resulting in a 75% reduction in hepatic SR-BI protein levels and intracellular mislocalization of the remaining SR-BI. As a consequence, the plasma lipoproteins in PDZ1 transgenic mice resembled those in PDZK1 KO mice (hypercholesterolemia due to large HDL). These results indicate that the PDZ1 domain can control the abundance and localization, and therefore the function, of hepatic SR-BI and that structural features of PDZK1 in addition to its SR-BI-binding PDZ1 domain are required for normal hepatic SR-BI regulation.

Highlights

  • The high density lipoprotein (HDL)3 receptor SR-BI plays a key role in lipoprotein metabolism [1] by mediating the cellular uptake of cholesteryl

  • The first PDZ domain, PDZ1, of the cytoplasmic adaptor protein PDZK1 binds to the C terminus of SR-BI, and as a consequence, PDZK1 controls hepatic SR-BI protein expression and lipoprotein metabolism [31, 32, 36]

  • We infer based on PDZ1 binding to SR-BI [31, 36], but have not demonstrated directly, that these effects were consequences of the recombinant, truncated PDZ1 domain competing with endogenous PDZK1 for binding to SR-BI

Read more

Summary

Introduction

The high density lipoprotein (HDL)3 receptor SR-BI (scavenger receptor, class B, type I) plays a key role in lipoprotein metabolism [1] by mediating the cellular uptake of cholesteryl. We have compared the effects of transgenes encoding either the full-length PDZK1 or only the SR-BI-binding PDZ1 domain on hepatic SR-BI protein expression and plasma lipoproteins in WT and PDZK1 KO mice.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call